Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A shows a slight decrease today, losing -€0.300 (-0.120%) compared to yesterday.
Our community is currently high on Bio-Rad Labs Inc. A with 5 Buy predictions and 0 Sell predictions.
With a target price of 334 € there is a positive potential of 34.79% for Bio-Rad Labs Inc. A compared to the current price of 247.8 €.
Our community identified positive and negative aspects for Bio-Rad Labs Inc. A stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bio-Rad Labs Inc. A stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | -0.120% | -7.052% | -3.916% | -27.607% | -3.916% | -43.810% | -47.722% |
| Icu Medical Inc. | -0.800% | -3.876% | 0.000% | -23.926% | 0.000% | -28.324% | -25.749% |
| Neogen Corp. | -1.720% | 3.012% | 39.024% | -22.973% | 39.024% | - | - |
| Haemonetics Corp. | 0.900% | -3.419% | -17.518% | - | -17.518% | - | - |
Comments
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BIO provided by MarketBeat